Related Experiment Video
Updated: Jun 25, 2026

Remote Limb Ischemic Preconditioning: A Neuroprotective Technique in Rodents
Published on: June 2, 2015
Autophagy is required for preconditioning by the adenosine A1 receptor-selective agonist CCPA
Smadar Yitzhaki1, Chengqun Huang, Wayne Liu
1BioScience Center, San Diego State University, San Diego, CA 92182-4650, USA.
Insights
Adenosine pretreatment enhances cardioprotection against ischemia/reperfusion injury by inducing macroautophagy, a cellular self-degradation process. Blocking autophagy eliminates adenosine
Area of Science:
- Cardiovascular Biology
- Cellular Biology
- Molecular Medicine
Background:
- Macroautophagy is a cellular process that protects cardiomyocytes from simulated ischemia/reperfusion (sI/R).
- Adenosine mimics ischemic preconditioning, a cardioprotective phenomenon, by affecting early and late phases.
Purpose of the Study:
- To determine the effect of adenosine on autophagosome formation.
- To investigate the role of adenosine-induced autophagy in cardioprotection against sI/R.
Main Methods:
- Investigated adenosine receptor agonists' effects on autophagy and cell survival in GFP-LC3 infected HL-1 cells and neonatal rat cardiomyocytes.
- Utilized A(1) adenosine receptor agonist (CCPA), antagonist, phospholipase C inhibitor, and Ca(+2) chelator.
- Blocked autophagy using a dominant-negative inhibitor (Atg5(K130R)) in HL-1 and adult rat cardiomyocytes.
- Assessed in vivo autophagy induction using mCherry-LC3 transgenic mice.
Main Results:
- The A(1) adenosine receptor agonist CCPA increased autophagosome formation within 10 minutes, persisting for at least 300 minutes.
- Inhibition of autophagy or A(1) receptor signaling abolished CCPA's protection against sI/R-induced cell death (measured by LDH release).
- Blocking autophagy with Atg5(K130R) eliminated CCPA's protective effect against sI/R.
- CCPA treatment significantly increased autophagosome formation in the hearts of mCherry-LC3 transgenic mice.
Conclusions:
- Adenosine, via A(1) receptor activation, induces macroautophagy in cardiomyocytes.
- Adenosine-mediated cardioprotection against sI/R is dependent on the induction of autophagy.
- Autophagy plays a critical role in mediating the protective effects of adenosine pretreatment in the heart.
Abstract:
We have shown that the cellular process of macroautophagy plays a protective role in HL-1 cardiomyocytes subjected to simulated ischemia/reperfusion (sI/R) (Hamacher-Brady et al. in J Biol Chem 281(40):29776-29787). Since the nucleoside adenosine has been shown to mimic both early and late phase ischemic preconditioning, a potent cardioprotective phenomenon, the purpose of this study was to determine the effect of adenosine on autophagosome formation. Autophagy is a highly regulated intracellular degradation process by which cells remove cytosolic long-lived proteins and damaged organelles, and can be monitored by imaging the incorporation of microtubule-associated light chain 3 (LC3) fused to a fluorescent protein (GFP or mCherry) into nascent autophagosomes. We investigated the effect of adenosine receptor agonists on autophagy and cell survival following sI/R in GFP-LC3 infected HL-1 cells and neonatal rat cardiomyocytes. The A(1) adenosine receptor agonist 2-chloro-N(6)-cyclopentyladenosine (CCPA) (100 nM) caused an increase in the number of autophagosomes within 10 min of treatment; the effect persisted for at least 300 min. A significant inhibition of autophagy and loss of protection against sI/R measured by release of lactate dehydrogenase (LDH), was demonstrated in CCPA-pretreated cells treated with an A(1) receptor antagonist, a phospholipase C inhibitor, or an intracellular Ca(+2) chelator. To determine whether autophagy was required for the protective effect of CCPA, autophagy was blocked with a dominant negative inhibitor (Atg5(K130R)) delivered by transient transfection (in HL-1 cells) or protein transduction (in adult rat cardiomyocytes). CCPA attenuated LDH release after sI/R, but protection was lost when autophagy was blocked. To assess autophagy in vivo, transgenic mice expressing the red fluorescent autophagy marker mCherry-LC3 under the control of the alpha myosin heavy chain promoter were treated with CCPA 1 mg/kg i.p. Fluorescence microscopy of cryosections taken from the left ventricle 30 min after CCPA injection revealed a large increase in the number of mCherry-LC3-labeled structures, indicating the induction of autophagy by CCPA in vivo. Taken together, these results indicate that autophagy plays an important role in mediating the cardioprotective effects conferred by adenosine pretreatment.
More Related Videos
09:50Application of Chronic Stimulation to Study Contractile Activity-induced Rat Skeletal Muscle Phenotypic Adaptations
Published on: January 25, 2018
07:46Bilateral Common Carotid Artery Occlusion as an Adequate Preconditioning Stimulus to Induce Early Ischemic Tolerance to Focal Cerebral Ischemia
Published on: May 9, 2013
Related Concept Videos
cAMP-dependent Protein Kinase Pathways
Desensitization and Tachyphylaxis
Several...
GPCRs Regulate Adenylyl Cylase Activity
Two...
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Anaphase Promoting Complex